Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
| Sales | 6,917 | 1,909 | 1,774 | 1,831 | 1,289 |
| Cost of Goods | 2,896 | 728 | 763 | 760 | 441 |
| Gross Profit | 4,021 | 1,181 | 1,011 | 1,071 | 848 |
| Operating Expenses | 4,913 | 7,498 | 8,816 | 7,839 | 8,346 |
| Operating Income | 4 | -5,589 | -7,042 | -6,008 | -7,057 |
| Interest Expense | 5 | 6 | 8 | 5 | 10 |
| Other Income | 5 | -959 | -392 | -250 | -7,304 |
| Pre-tax Income | 4 | -6,554 | -7,442 | -6,263 | -14,371 |
| Net Income Continuous | 4 | -6,554 | -7,442 | -6,263 | -14,371 |
| Net Income | $4 | $-6,554 | $-7,442 | $-6,263 | $-14,371 |
| EPS Basic Total Ops | 0.00 | -0.09 | -0.11 | -0.10 | -0.25 |
| EPS Basic Continuous Ops | 0.00 | -0.09 | -0.11 | -0.10 | -0.25 |
| EPS Diluted Total Ops | 0.00 | -0.09 | -0.11 | -0.10 | -0.25 |
| EPS Diluted Continuous Ops | 0.00 | -0.09 | -0.11 | -0.10 | -0.25 |
| EBITDA(a) | $200 | $-5,310 | $-6,635 | $-5,588 | $-6,613 |